Synapse - Andrew Zelenetz

Results (785)

Clinical outcomes of patients treated with rituximab for relapsed or refractory aggressive non-Hodgkin's lymphoma in the post-transplant setting

Meeting Abstract

Pan, D.; Moskowitz, C. H.; Zelenetz, A. D.; Teruya-Feldstein, J.; Portlock, C. S.
Blood (2000)

Fulltext@MSK | Save

Ig heavy chain PCR of serum and plasma fails as a reliable source of minimal residual disease (MRD) in patients with B cell intermediate grade lymphoma

Meeting Abstract

Noy, A.; Davoli, E.; Moskowitz, C. H.; Zelenetz, A. D.
Blood (2000)

Fulltext@MSK | Save

Vaccination with CD20 peptide conjugates induces a biologically active, specific immune response in mice

Meeting Abstract

Roberts, W. K.; Agus, D.; Pinilla-Ibarz, J.; Zelenetz, A.; Livingston, P. O.; Scheinberg, D. A.
Blood (2000)

Fulltext@MSK | Save

MUC 1 and MDC 15 dysregulation in extra-nodal B-cell lymphomas

Meeting Abstract

Gilles, F.; Goy, A.; Remache, Y.; Zelenetz, A. D.
Blood (2000)

Fulltext@MSK | Save

Review of patterns of care among community physicians in intermediate grade NHL (IGL) reveals significantly greater planned and delivered dose attenuation in older patients

Meeting Abstract

Zelenetz, A. D.; Reider, P. A.; Delgado, D. J.
Blood (2000)

Fulltext@MSK | Save

Translocation t(14;18) in healthy individuals: Preliminary study of its association with family history and agricultural exposure

Journal Article

Paltiel, O.; Zelenetz, A.; Sverdlin, I.; Gordon, L.; Ben-Yehuda, D.
Annals of Oncology (2000)

Fulltext@MSK | Save

Granulocyte-colony stimulating factor (G-CSF) may improve disease outcome in elderly patients with diffuse large cell lymphoma (DLCL) treated with CHOP chemotherapy

Journal Article

Donnelly, G. B.; Glassman, J.; Long, C.; Torres, P.; Straus, D. J.; O'Brien, J. P.; Bertino, J.; Moskowitz, C. H.; Zelenetz, A. D.; Portlock, C. S.
Leukemia and Lymphoma (2000)

Fulltext@MSK | Save

Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy

Journal Article

Weiss, M. A.; Glenn, M.; Maslak, P.; Rahman, Z.; Noy, A.; Zelenetz, A.; Scheinberg, D. A.; Golde, D. W.
Leukemia (2000)

Fulltext@MSK | Save

Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas